https://www.outlookindia.com/newsscroll/avenue-therapeutics-gets-complete-response-letter-from-usfda-for-intravenous-tramadol/1953945
update on a possible big drug for ciplas subsidiary
regards
divyansh
https://www.outlookindia.com/newsscroll/avenue-therapeutics-gets-complete-response-letter-from-usfda-for-intravenous-tramadol/1953945
update on a possible big drug for ciplas subsidiary
regards
divyansh